Cold Chain Webcast: What a 3PL, a Tech Vendor, and a Packaging Firm Agree On

Last updated: October 12, 2026

A webcast series on cold chain operations has brought together executives from a US woman-owned 3PL, a major technology vendor, and a temperature-controlled packaging firm. The panel covers geopolitical impact, innovation, and operational discipline across the cold chain, with the underlying message that the sector's risk profile has changed for good.

For our readers running temperature-sensitive freight, the conversation is directly relevant. Cold chain is one of the few segments of logistics where the cost of failure is measured in destroyed product, not delayed delivery, and the lessons from a multi-vendor panel are worth distilling.

What happened

• The session is one episode in a multi-part series aimed at refining cold chain operations.
• Panelists come from a US woman-owned 3PL, a global technology vendor, and a temperature-controlled packaging firm.
• Topics include geopolitical pressure on cold chain businesses, innovation, and technology adoption.
• The 3PL is based in Indianapolis and runs supply chain, freight, and warehouse services in the Midwest and Southeastern US.
• The packaging firm specialises in temperature-controlled packaging for life sciences and food.
• The technology vendor contributes the visibility and tracking layer that increasingly underpins cold chain compliance.

Who is on the panel

The three companies are a freight management company, a tracking and visibility technology provider, and a temperature-controlled packaging specialist. Cathy Langham, owner and president, represents the 3PL's customer-facing perspective. Chris Caulfield, Vice President of Temporary Operations, represents the visibility and tracking technology stack. Ranjeet Banerjee, CEO, and Anthony Rizzo, Chief Commercial Officer, represent the packaging side that determines whether a temperature-controlled payload arrives in spec.

The format is a panel discussion, not a product pitch, but the combination is a useful proxy for how a real cold chain operation works. The packaging, the visibility layer, and the 3PL orchestration all have to line up for the shipment to succeed. The webcast's framing of "change at a glance" is an honest one: the sector is in the middle of a structural shift, and the panel is a snapshot of the parts that are moving fastest.

Why the cold chain conversation has changed

Two forces have reshaped the cold chain over the last three years. The first is the pandemic-era surge in pharmaceutical and biologics distribution, which raised both the volume and the compliance bar. The second is the broader geopolitical and supply chain disruption that has made resilience a procurement criterion, not just a cost line. Cold chain operations have had to absorb both at the same time, and the operational playbooks from 2019 no longer fully apply.

For Israeli readers, the more relevant shift is the rise of pharma and biotech cold chain demand tied to Israeli-developed therapeutics. The country is a meaningful exporter of specialty pharmaceuticals, and the cold chain that supports that export is increasingly built by international 3PLs with the right certifications.

Our analysis

The interesting thing about a three-vendor cold chain panel is that the consensus usually lands in a small number of places: visibility is non-negotiable, packaging is undervalued as a risk control, and the customer-facing 3PL is the integration layer that holds the rest together. None of that is a new insight, but the fact that three different vendors converge on it is the news.

The other under-discussed point is workforce. Cold chain operations are labour-intensive at the warehouse and packing level, and the labour market in the US and Europe has tightened. A cold chain that depends on a small, well-trained team is a cold chain that is one retirement away from a service failure. The 3PLs that are scaling are the ones that have invested in training and process documentation, not just hardware.

A practical example

Say you are shipping a temperature-sensitive biologic from a manufacturer in the Tel Aviv area to a clinical trial site in the US, with a transit time of around 48 hours and a required temperature window of 2 to 8°C. The shipment will touch a local courier, an international airline, a US customs broker, a US ground carrier, and a final-mile courier. The risk is not in any single leg; it is in the handoffs. A cold chain panel of this kind would tell you to instrument every handoff with a temperature and location logger, to validate the packaging qualification for the actual lane, and to keep the 3PL accountable for the whole chain, not just the leg they touch.

What to watch next

Watch for the next episode in the webcast series, and the practical case studies that follow. The 3PL industry runs on word-of-mouth case studies more than on marketing material, and the cold chain is no exception.